Fabrication and evaluation of valsartan-polymer- surfactant composite nanoparticles by using the supercritical antisolvent process. [electronic resource]
Producer: 20150709Description: 5167-76 p. digitalISSN:- 1178-2013
- Administration, Oral
- Animals
- Biological Availability
- Hypromellose Derivatives -- chemistry
- Male
- Nanocomposites -- administration & dosage
- Nanotechnology -- methods
- Poloxamer -- chemistry
- Rats
- Rats, Sprague-Dawley
- Solubility
- Surface-Active Agents -- administration & dosage
- Tetrazoles -- administration & dosage
- Valine -- administration & dosage
- Valsartan
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.